Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...
GlobalData on MSN1d
EC approves CSL’s Andembry to stop hereditary angioedema attacksCSL has received approval from the European Commission (EC) for Andembry (garadacimab) to prevent recurrent attacks of ...
In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...
Get Jubilant Agri & Consumer Products today's stock price, 52-week high, 52-week low, Jubilant Agri & Consumer Products quarterly results, share performance, financials, peer comparison, technicals, ...
Researchers provided a long-awaited and rare genetic diagnosis in a child with Lennox-Gastaut syndrome, a type of ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...
THE government is seeking a US$5,31 million grant from the African Development Bank (AfDB) to support the development of the beef and leather value chain. The support is part of the Zimbabwe ...
Weeran Angus are heading into their 54th Bull Sale at 1pm on Tuesday, February 25, 2025, and they invite you to go and visit ...
PARIS, France I February 12, 2025 I GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback